Murad, Inc. Participates In Electronic Retailing Self-Regulation Program

New York, NY – February 16, 2005 – The Electronic Retailing Self-Regulation Program (“ERSP”), the electronic direct -response industry’s self-regulatory program supervised by the National Advertising Review Council (“NARC”), announced that direct response marketer Murad, Inc.

provided a reasonable basis for its claims “Get Clear. Stay Clear” for acne,  that the Murad Acne Complex has a “90% success rate” as effectively treating acne conditions, and that the Murad Acne Complex effectively treats the visible factors of breakouts, but did not support a claim that the Murad Acne Complex treats “all of the reasons” why your skin may breakout. ERSP also concluded that the advertising communicated an implied claim that the Murad Acne Complex can effectively “treat” (i.e. cure) the seven specific skin conditions, a representation that was neither intended nor supported by the marketer. The truth and accuracy of the marketer’s claims came to the attention of ERSP through an anonymous competitor challenge.

In the inquiry, ERSP requested that the marketer provide substantiation for several core performance claims that were communicated in the 30-minute advertisement for the Murad Acne Complex. The core claims at issue in the advertisement pertained to: a) the effectiveness of the product to work as a treatment for several very serious skin conditions (Folliculitis, eczema, keratosis pilaris, peri-oral dermatitis, excoree and rosacea); b) the ability of the product to help consumers “Get Clear” and “ Stay Clear” of skin breakouts; c) the ability of  the product to treat “all of the reasons your skin may breakout” and; d) clinical results showing a “90% Success Rate.”

In its response to the determination, the marketer informed ERSP that while it “respectfully disagrees with certain of the conclusions reached by ERSP,” it had already planned to discontinue the infomercial at issue in the subject challenge. Murad did agree to “take the recommendations of the ERSP in to consideration in developing future advertising for the ACNE Complex. ”

 

Subscribe to the Ad Law Insights or Privacy Initiatives newsletters for an exclusive monthly analysis and insider perspectives on the latest trends and case decisions in advertising law and data privacy.

 

 

 

 

Latest Decisions

Decision

National Advertising Division Recommends Blueprint Test Preparation Discontinue Certain MCAT Score Improvement Claims

New York, NY – April 22, 2024 – The National Advertising Division recommended Blueprint Test Preparation discontinue certain express and implied claims made in connection with its four MCAT preparation courses, including claims that Blueprint students raise their MCAT scores by 15 or 13 points on average.

Read the Decision Summary
Decision

National Advertising Division Recommends The Princeton Review Discontinue Point Increase Claims for MCAT Test Preparation Services

New York, NY – April 18, 2024 – In a Fast-Track SWIFT challenge, the National Advertising Division recommended that The Princeton Review (TPR) discontinue claims that its students “Score a 515+ on the MCAT or add 15 points depending on your starting score. Guaranteed or your money back.”

Read the Decision Summary
Decision

Direct Selling Self-Regulatory Council Recommends Trades of Hope Discontinue Salesforce Member Earnings Claims

McLean, VA – April 17, 2024 – The Direct Selling Self-Regulatory Council (DSSRC) recommended that Trades of Hope discontinue certain earnings claims made by salesforce members on Facebook and YouTube. 

Read the Decision Summary
Decision

National Advertising Division Recommends Lily of the Desert Nutraceuticals Discontinue “100% Pure Avocado Oil” Claim for Tropical Plantation Avocado Oil

New York, NY – April 15, 2024 – The National Advertising Division recommended that Lily of the Desert Nutraceuticals discontinue the claim “100% Pure Avocado Oil” for its Tropical Plantation Avocado Oil and avoid conveying the unsupported message that the product is 100% pure avocado...

Read the Decision Summary